CD274 and neoplasm: ELISA analysis of tumor-associated cytokines revealed that the combination of Liensinine and PD-L1 inhibitors significantly reduced levels of pro-tumorigenic cytokines, while concurrently elevating the levels of cytokines associated with tumor suppression and cytotoxicity (Fig. 6O).